PROP1 and hypopituitarism: In patients with combined pituitary hormone deficiencies, the most frequently identified mutations were in PROP1 (11.6% of patients), followed by LHX3 (1.2%), whereas the gene mutations in patients with isolated GH deficiency were most frequently found in GH1 (4.8%), and GHRHR (1.1%).